Relative Bioavailability Study of GSK1265744 Formulations

NCT01648257 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Human Immunodeficiency Virus and Hepatitis

Interventions

DRUG: GSK1265744 Na Salt Tablets
DRUG: GSK1265744 Free Acid Nanomilled Capsules
DRUG: GSK1265744 Free Acid Micronized Capsules

Sponsor

ViiV Healthcare